The oncomir miR-17-5p targets anti-tumoral phosphatase and tensin homolog (PTEN), which controls activation of the Akt-mTOR pathway in thyroid cancer (Shi et al., 2020) (Table 2). This evidence concerns the gene PTEN and thyroid cancer.